BPC-157

Research

Body Protection Compound 157

Aliases
PL 14736, Bepecin
Administration
Subcutaneous injection, Intramuscular injection, Oral (limited bioavailability)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Generally well-tolerated

Most users do not report significant adverse effects.

Nausea (anecdotal reports)

Some users have informally reported nausea, though this has not been rigorously documented in clinical studies.